SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-02-17
👔
BIOGEN INC.
@BIIB_InsiderForm 4 Filing: Izzar Rachid Acquires (Grant) shares of $BIIB
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
BIOGEN INC.
Ticker: $BIIB
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-02-13
Shares: 7,390
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Izzar Rachid, holds the title of Head of Global Product Strat. at BIOGEN INC..
On 2026-02-13, the insider transacted 7,390 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Izzar Rachid (Head of Global Product Strat.) was granted $0 of $BIIB
Post-Transaction Position: 7,390 shares
SEC Accession No: 0000875045-26-000030 (CIK: 1875506)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.